UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight

Advances in experimental medicine and biology, 2008, Vol.624, p.89

2008

Volltextzugriff (PDF)

Partial Histological Tumor Regression in Primary Melanoma as Protective Factor for Lymph Node Micrometastasis

JAMA dermatology (Chicago, Ill.), 2015-12, Vol.151 (12), p.1291

Garbe, Claus

2015

Volltextzugriff (PDF)

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Clinical cancer research, 2016-06, Vol.22 (12), p.2908-2918

2016

Volltextzugriff (PDF)

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

The oncologist (Dayton, Ohio), 2011-01, Vol.16 (1), p.5-24

2011

Volltextzugriff (PDF)

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT

Molecular cancer research, 2018-07, Vol.16 (7), p.1149-1160

2018

Volltextzugriff (PDF)

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.180-180, Article 180

2019

Volltextzugriff (PDF)

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

European journal of nuclear medicine and molecular imaging, 2018-01, Vol.45 (1), p.95-101

2018

Volltextzugriff (PDF)

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Clinical cancer research, 2017-10, Vol.23 (20), p.6203-6214

2017

Volltextzugriff (PDF)

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Journal for immunotherapy of cancer, 2019-12, Vol.7 (1), p.343-343, Article 343

2019

Volltextzugriff (PDF)

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach

European journal of nuclear medicine and molecular imaging, 2020-09, Vol.47 (10), p.2313-2321

2020

Volltextzugriff (PDF)

The ROS‐induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF‐1alpha in the NCI60 cancer cell lines

Journal of cellular and molecular medicine, 2014-03, Vol.18 (3), p.530-541

2014

Volltextzugriff (PDF)

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial

Journal for immunotherapy of cancer, 2023-05, Vol.11 (5), p.e006270

2023

Volltextzugriff (PDF)

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells

Science signaling, 2013-01, Vol.6 (260), p.ra7

2013

Volltextzugriff (PDF)

Epidemiology of Skin Cancer: Update 2019

Sunlight, Vitamin D and Skin Cancer, p.123-139

Volltextzugriff (PDF)

The natural course of cutaneous melanoma

Journal of surgical oncology, 2004-07, Vol.86 (4), p.172-178

2004

Volltextzugriff (PDF)

Genomics of Immunotherapy-Associated Hyperprogressors-Letter

Clinical cancer research, 2017-10, Vol.23 (20), p.6374-6375

2017

Volltextzugriff (PDF)

Epidemiology of skin cancer

Advances in experimental medicine and biology, 2014, Vol.810, p.120

2014

Volltextzugriff (PDF)

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006802

2023

Volltextzugriff (PDF)

The increased expression of Y box‐binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance

International journal of cancer, 2007-05, Vol.120 (10), p.2110-2118

2007

Volltextzugriff (PDF)

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

Experimental dermatology, 2017-07, Vol.26 (7), p.598-606

2017

Volltextzugriff (PDF)

The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytes

Pigment cell and melanoma research, 2011-06, Vol.24 (3), p.438-445

2011

Volltextzugriff (PDF)

In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival

Pigment cell and melanoma research, 2014-07, Vol.27 (4), p.671-673

2014

Volltextzugriff (PDF)

The adhesion molecule L1 (CD171) promotes melanoma progression

International journal of cancer, 2006-08, Vol.119 (3), p.549-555

2006

Volltextzugriff (PDF)

Non-melanoma skin cancer: new and future synthetic drug treatments

Expert opinion on pharmacotherapy, 2017-05, Vol.18 (7), p.689-699

2017

Volltextzugriff (PDF)

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

International journal of dermatology, 2011-02, Vol.50 (2), p.129-146

2011

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

KollektionIngenta

KollektioneBooks on EBSCOhost

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(348)
Mit Volltextzugriff
(340)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight

Partial Histological Tumor Regression in Primary Melanoma as Protective Factor for Lymph Node Micrometastasis

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

YB-1 Expression and Phosphorylation Regulate Tumorigenicity and Invasiveness in Melanoma by Influencing EMT

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach

The ROS‐induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF‐1alpha in the NCI60 cancer cell lines

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells

Epidemiology of Skin Cancer: Update 2019

The natural course of cutaneous melanoma

Genomics of Immunotherapy-Associated Hyperprogressors-Letter

Epidemiology of skin cancer

Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

The increased expression of Y box‐binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytes

In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival

The adhesion molecule L1 (CD171) promotes melanoma progression

Non-melanoma skin cancer: new and future synthetic drug treatments

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

Aktive Filter

Suchergebnisse filtern